Biofilms Treatment Market by Products (Debridement Equipment, Gauze, Dressing, Gel, Ointment), Wound Type (Traumatic, Surgical, Open, Diabetic Foot, Venous Leg Ulcer & Burns), End User (Hospital, ASCs, Wound Care Centers, Homecare)-Global Forecast to 2025

Biofilms Treatment Market by Products (Debridement Equipment, Gauze, Dressing, Gel, Ointment), Wound Type (Traumatic, Surgical, Open, Diabetic Foot, Venous Leg Ulcer & Burns), End User (Hospital, ASCs, Wound Care Centers, Homecare)-Global Forecast to 2025

“Rising incidence of burn injuries is driving the growth of the biofilms treatment market”
The biofilms treatment market is projected to reach USD 2.4 billion by 2025 from USD 1.6 billion in 2020, at a CAGR of 7.9%. The growth of this market is majorly driven by the rising prevalence of chronic, surgical, and traumatic wounds and the increasing incidence of burn injuries. However, the high cost and low adoption rate of advanced wound care products are expected to limit the growth of this market to a certain extent.

“Gauzes and dressings segment accounted for the largest share of the biofilms treatment market in 2019”
Based on product, the biofilms treatment market is segmented into debridement equipment; gauzes and dressings; gels, ointments, and sprays; wipes, pads, and lavage solutions; and grafts and matrices. The gauzes and dressings segment accounted for the largest market share in 2019. This can be attributed to the ability of antimicrobial products to remove, prevent, and manage biofilms.

“Traumatic and surgical wounds segment will continue to dominate the biofilms treatment market during the forecast period”
Based on wound type, the biofilms treatment market is segmented into surgical and traumatic wounds, diabetic foot ulcers, pressure ulcers, venous leg ulcers, and burns and other open wounds. The surgical and traumatic wounds segment accounted for the largest market share in 2019. The large share of this segment can be attributed to the growing prevalence of diabetes and the increasing number of surgical procedures performed.

“North America dominates the global biofilms treatment market”
In 2019, North America accounted for the largest share of the biofilms treatment market, and this trend is expected to continue during the forecast period. The large share of this market can be attributed to the increasing incidence of chronic wounds, rising healthcare expenditure, the introduction of novel and specialty biofilm management products, and the presence of major market players in this region.

The primary interviews conducted for this report can be categorized as follows:
By Company Type: Tier 1 - 36%, Tier 2 - 45%, and Tier 3 - 19%
By Designation: C-level - 33%, D-level - 40%, and Others - 27%
By Region: North America - 39%, Europe - 30%, Asia Pacific - 20%, Latin America- 8%, and the Middle East and Africa- 3%

List of Companies Profiled in the Report
Smith & Nephew (UK)
MiMedx Group Inc. (US)
ConvaTec Group plc (UK)
Coloplast A/S (Denmark)
Mölnlycke Healthcare AB (Sweden)
Organogenesis Holdings Inc. (US)
Integra LifeSciences Holdings Corporation (US)
B. Braun Melsungen AG (Germany)
PAUL HARTMANN AG (Germany)
Medline Industries Inc. (US)
Acelity (US)
Misonix (US)
Zimmer Biomet Holdings Inc. (US)
Kerecis (Iceland)
Welcare Industries S.p.A (Italy)
Medaxis AG (Switzerland)
PulseCare Medical (US)
Arobella Medical, LLC (UK)
RLS Global AB (Sweden)
Mil Laboratories Pvt. Ltd. (India)

Research Coverage:
This report provides a detailed picture of the global biofilms treatment market. It aims at estimating the size and future growth potential of the market across different segments, such as product, end user, wound type, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall biofilms treatment market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to position their business better and make suitable go-to-market strategies. This report will enable stakeholders to understand the pulse of the market and provide them with information on the key market drivers, restraints, and opportunities.


  • INTRODUCTION
    • OBJECTIVES OF THE STUDY
    • MARKET DEFINITION
      • Table INCLUSIONS & EXCLUSIONS
      • MARKET SCOPE
      • YEARS CONSIDERED FOR THE STUDY
    • CURRENCY
    • LIMITATIONS
    • STAKEHOLDERS
  • RESEARCH METHODOLOGY
    • RESEARCH DATA
    • RESEARCH APPROACH
      • SECONDARY DATA
      • PRIMARY DATA
    • MARKET SIZE ESTIMATION
      • BOTTOM-UP APPROACH
      • TOP-DOWN APPROACH
    • MARKET BREAKDOWN AND DATA TRIANGULATION
    • ASSUMPTIONS FOR THE STUDY
  • EXECUTIVE SUMMARY
  • PREMIUM INSIGHTS
    • BIOFILMS TREATMENT MARKET OVERVIEW
    • BIOFILMS TREATMENT MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION)
    • BIOFILMS TREATMENT MARKET SHARE, BY END USER, 2020 VS. 2025
    • BIOFILMS TREATMENT MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • MARKET OVERVIEW
    • INTRODUCTION
    • MARKET DYNAMICS
      • DRIVERS
      • OPPORTUNITIES
      • CHALLENGES
  • BIOFILMS TREATMENT MARKET, BY PRODUCT
    • INTRODUCTION
      • Table AVERAGE SELLING PRICE OF VARIOUS PRODUCTS USED IN THE BIOFILMS TREATMENT MARKET (USD)
      • Table GLOBAL BIOFILMS TREATMENT MARKET BY PRODUCT, 2018–2025 (USD MILLION)
    • DEBRIDEMENT EQUIPMENT
      • DEVELOPMENT OF NOVEL TECHNOLOGIES TO SUPPORT MARKET GROWTH
        • Table DEBRIDEMENT EQUIPMENT MARKET, BY REGION, 2018–2025 (USD MILLION)
        • Table NORTH AMERICA: DEBRIDEMENT EQUIPMENT MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
        • Table EUROPE: DEBRIDEMENT EQUIPMENT MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
        • Table APAC: DEBRIDEMENT EQUIPMENT MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
    • GAUZES AND DRESSINGS
      • GAUZES AND DRESSINGS ARE DESIGNED TO PREVENT THE OCCURRENCE OF INFECTIONS AFTER DEBRIDEMENT PROCEDURES
        • Table GAUZES AND DRESSINGS MARKET, BY REGION, 2018–2025 (USD MILLION)
        • Table NORTH AMERICA: GAUZES AND DRESSINGS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
        • Table EUROPE: GAUZES AND DRESSINGS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
        • Table APAC: GAUZES AND DRESSINGS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
    • GRAFTS AND MATRICES
      • GRAFTS AND MATRICES PROMOTE HEALING AND WOUND CLOSURE
        • Table GRAFTS AND MATRICES MARKET, BY REGION, 2018–2025 (USD MILLION)
        • Table NORTH AMERICA: GRAFTS AND MATRICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
        • Table EUROPE: GRAFTS AND MATRICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
        • Table APAC: GRAFTS AND MATRICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
    • WIPES, PADS, AND LAVAGE SOLUTIONS
      • LAVAGE SOLUTIONS ARE USED FOR CLEANING WOUNDS DURING HYDRO SURGICAL AND MECHANICAL DEBRIDEMENT PROCEDURES
        • Table WIPES, PADS, AND LAVAGE SOLUTIONS MARKET, BY REGION, 2018–2025 (USD MILLION)
        • Table NORTH AMERICA: WIPES, PADS, AND LAVAGE SOLUTIONS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
        • Table EUROPE: WIPES, PADS, AND LAVAGE SOLUTIONS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
        • Table APAC: WIPES, PADS, AND LAVAGE SOLUTIONS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
    • GELS, OINTMENTS, AND SPRAYS
      • THESE PRODUCTS ARE USED TO TREAT BURNS, DIABETIC FOOT ULCERS, AND SURGICAL & TRAUMATIC WOUNDS
        • Table GELS, OINTMENTS, AND SPRAYS MARKET, BY REGION, 2018–2025 (USD MILLION)
        • Table NORTH AMERICA: GELS, OINTMENTS, AND SPRAYS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
        • Table EUROPE: GELS, OINTMENTS, AND SPRAYS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
        • Table APAC: GELS, OINTMENTS, AND SPRAYS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
  • BIOFILMS TREATMENT MARKET, BY WOUND TYPE
    • INTRODUCTION
      • Table BIOFILMS TREATMENT MARKET, BY WOUND TYPE, 2018–2025 (USD MILLION)
    • SURGICAL AND TRAUMATIC WOUNDS
      • GROWING VOLUME OF SURGICAL PROCEDURES PERFORMED TO SUPPORT MARKET GROWTH
        • Table BIOFILMS TREATMENT MARKET FOR SURGICAL AND TRAUMATIC WOUNDS, BY REGION, 2018–2025 (USD MILLION)
    • DIABETIC FOOT ULCERS
      • RISING PREVALENCE OF DIABETES IS A KEY FACTOR DRIVING THE GROWTH OF THIS SEGMENT
        • Table BIOFILMS TREATMENT MARKET FOR DIABETIC FOOT ULCERS, BY REGION, 2018–2025 (USD MILLION)
    • PRESSURE ULCERS
      • GERIATRIC POPULATION IS MORE SUSCEPTIBLE TO DEVELOPING PRESSURE ULCERS
        • Table BIOFILMS TREATMENT MARKET FOR PRESSURE ULCERS, BY REGION, 2018–2025 (USD MILLION)
    • VENOUS LEG ULCERS
      • INCREASING PREVALENCE OF OBESITY TO SUPPORT MARKET GROWTH
        • Table BIOFILMS TREATMENT MARKET FOR VENOUS LEG ULCERS, BY REGION, 2018–2025 (USD MILLION)
    • BURNS & OTHER OPEN WOUNDS
      • INCIDENCE OF BURN INJURIES IS HIGH IN EMERGING COUNTRIES
        • Table HOSPITAL ADMISSIONS FOR THE TREATMENT OF BURN INJURIES, 2015
        • Table BIOFILMS TREATMENT MARKET FOR BURNS AND OTHER OPEN WOUNDS, BY REGION, 2018–2025 (USD MILLION)
  • BIOFILMS TREATMENT MARKET, BY END USER
    • INTRODUCTION
      • Table BIOFILMS TREATMENT MARKET, BY END USER, 2018–2025 (USD MILLION)
    • HOSPITALS, ASCS, AND WOUND CARE CENTERS
      • RISING INCIDENCE OF HOSPITAL-ACQUIRED PRESSURE ULCERS AND INFECTIONS TO SUPPORT MARKET GROWTH
        • Table BIOFILMS TREATMENT MARKET FOR HOSPITALS, ASCS, AND WOUND CARE CENTERS, BY REGION, 2018–2025 (USD MILLION)
    • HOME CARE SETTINGS
      • RISING PREFERENCE FOR HOME HEALTHCARE IS CONTRIBUTING TO THE GROWTH OF THIS MARKET
        • Table BIOFILMS TREATMENT MARKET FOR HOME CARE SETTINGS, BY REGION, 2018–2025 (USD MILLION)
    • OTHER END USERS
      • Table BIOFILMS TREATMENT MARKET FOR OTHER END USERS, BY REGION, 2018–2025 (USD MILLION)
  • BIOFILMS TREATMENT MARKET, BY REGION
    • INTRODUCTION
      • Table BIOFILMS TREATMENT MARKET, BY REGION, 2018–2025 (USD MILLION)
      • Table NUMBER OF BIOFILM WOUND CASES, BY REGION, 2018–2025 (MILLION)
    • NORTH AMERICA
      • Table NORTH AMERICA: BIOFILMS TREATMENT MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
      • Table NORTH AMERICA: BIOFILMS TREATMENT MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
      • Table NORTH AMERICA: BIOFILMS TREATMENT MARKET, BY WOUND TYPE, 2018–2025 (USD MILLION)
      • Table NORTH AMERICA: BIOFILMS TREATMENT MARKET, BY END USER, 2018–2025 (USD MILLION)
      • US
        • Table US: BIOFILMS TREATMENT MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
        • Table US: BIOFILMS TREATMENT MARKET, BY WOUND TYPE, 2018–2025 (USD MILLION)
        • Table US: BIOFILMS TREATMENT MARKET, BY END USER, 2018–2025 (USD MILLION)
      • CANADA
        • Table CANADA: INCIDENCE OF DIABETES, 2016 VS. 2026
        • Table CANADA: BIOFILMS TREATMENT MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
        • Table CANADA: BIOFILMS TREATMENT MARKET, BY WOUND TYPE, 2018–2025 (USD MILLION)
        • Table CANADA: BIOFILMS TREATMENT MARKET, BY END USER, 2018–2025 (USD MILLION)
    • EUROPE
      • Table EUROPE: PREVALENCE OF DIABETES, 2015 VS. 2040
      • Table EUROPE: BIOFILMS TREATMENT MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
      • Table EUROPE: BIOFILMS TREATMENT MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
      • Table EUROPE: BIOFILMS TREATMENT MARKET, BY WOUND TYPE, 2018–2025 (USD MILLION)
      • Table EUROPE: BIOFILMS TREATMENT MARKET, BY END USER, 2018–2025 (USD MILLION)
      • UK
        • Table UK: BIOFILMS TREATMENT MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
        • Table UK: BIOFILMS TREATMENT MARKET, BY WOUND TYPE, 2018–2025 (USD MILLION)
        • Table UK: BIOFILMS TREATMENT MARKET, BY END USER, 2018–2025 (USD MILLION)
      • GERMANY
        • Table GERMANY: BIOFILMS TREATMENT MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
        • Table GERMANY: BIOFILMS TREATMENT MARKET, BY WOUND TYPE, 2018–2025 (USD MILLION)
        • Table GERMANY: BIOFILMS TREATMENT MARKET, BY END USER, 2018–2025 (USD MILLION)
      • RUSSIA
        • Table RUSSIA: BIOFILMS TREATMENT MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
        • Table RUSSIA: BIOFILMS TREATMENT MARKET, BY WOUND TYPE, 2018–2025 (USD MILLION)
        • Table RUSSIA: BIOFILMS TREATMENT MARKET, BY END USER, 2018–2025 (USD MILLION)
      • FRANCE
        • Table FRANCE: BIOFILMS TREATMENT MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
        • Table FRANCE: BIOFILMS TREATMENT MARKET, BY WOUND TYPE, 2018–2025 (USD MILLION)
        • Table FRANCE: BIOFILMS TREATMENT MARKET, BY END USER, 2018–2025 (USD MILLION)
      • ITALY
        • Table ITALY: BIOFILMS TREATMENT MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
        • Table ITALY: BIOFILMS TREATMENT MARKET, BY WOUND TYPE, 2018–2025 (USD MILLION)
        • Table ITALY: BIOFILMS TREATMENT MARKET, BY END USER, 2018–2025 (USD MILLION)
      • SPAIN
        • Table SPAIN: BIOFILMS TREATMENT MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
        • Table SPAIN: BIOFILMS TREATMENT MARKET, BY WOUND TYPE, 2018–2025 (USD MILLION)
        • Table SPAIN: BIOFILMS TREATMENT MARKET, BY END USER, 2018–2025 (USD MILLION)
      • REST OF EUROPE
        • Table ROE: BIOFILMS TREATMENT MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
        • Table ROE: BIOFILMS TREATMENT MARKET, BY WOUND TYPE, 2018–2025 (USD MILLION)
        • Table ROE: BIOFILMS TREATMENT MARKET, BY END USER, 2018–2025 (USD MILLION)
    • ASIA PACIFIC
      • Table APAC: BIOFILMS TREATMENT MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
      • Table APAC: BIOFILMS TREATMENT MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
      • Table APAC: BIOFILMS TREATMENT MARKET, BY WOUND TYPE, 2018–2025 (USD MILLION)
      • Table APAC: BIOFILMS TREATMENT MARKET, BY END USER, 2018–2025 (USD MILLION)
      • CHINA
        • Table CHINA: BIOFILMS TREATMENT MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
        • Table CHINA: BIOFILMS TREATMENT MARKET, BY WOUND TYPE, 2018–2025 (USD MILLION)
        • Table CHINA: BIOFILMS TREATMENT MARKET, BY END USER, 2018–2025 (USD MILLION)
      • JAPAN
        • Table JAPAN: BIOFILMS TREATMENT MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
        • Table JAPAN: BIOFILMS TREATMENT MARKET, BY WOUND TYPE, 2018–2025 (USD MILLION)
        • Table JAPAN: BIOFILMS TREATMENT MARKET, BY END USER, 2018–2025 (USD MILLION)
      • INDIA
        • Table INDIA: BIOFILMS TREATMENT MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
        • Table INDIA: BIOFILMS TREATMENT MARKET, BY WOUND TYPE, 2018–2025 (USD MILLION)
        • Table INDIA: BIOFILMS TREATMENT MARKET, BY END USER, 2018–2025 (USD MILLION)
      • AUSTRALIA
        • Table AUSTRALIA: BIOFILMS TREATMENT MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
        • Table AUSTRALIA: BIOFILMS TREATMENT MARKET, BY WOUND TYPE, 2018–2025 (USD MILLION)
        • Table AUSTRALIA: BIOFILMS TREATMENT MARKET, BY END USER, 2018–2025 (USD MILLION)
      • REST OF ASIA PACIFIC
        • Table TOTAL DIABETES-RELATED HEALTH EXPENDITURE, 2019 VS. 2030 (USD MILLION)
        • Table ROAPAC: BIOFILMS TREATMENT MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
        • Table ROAPAC: BIOFILMS TREATMENT MARKET, BY WOUND TYPE, 2018–2025 (USD MILLION)
        • Table ROAPAC: BIOFILMS TREATMENT MARKET, BY END USER, 2018–2025 (USD MILLION)
    • LATIN AMERICA
      • Table LATAM: BIOFILMS TREATMENT MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
      • Table LATAM: BIOFILMS TREATMENT MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
      • Table LATAM: BIOFILMS TREATMENT MARKET, BY WOUND TYPE, 2018–2025 (USD MILLION)
      • Table LATAM: BIOFILMS TREATMENT MARKET, BY END USER, 2018–2025 (USD MILLION)
      • BRAZIL
        • Table BRAZIL: BIOFILMS TREATMENT MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
        • Table BRAZIL: BIOFILMS TREATMENT MARKET, BY WOUND TYPE, 2018–2025 (USD MILLION)
        • Table BRAZIL: BIOFILMS TREATMENT MARKET, BY END USER, 2018–2025 (USD MILLION)
      • MEXICO
        • Table MEXICO: BIOFILMS TREATMENT MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
        • Table MEXICO: BIOFILMS TREATMENT MARKET, BY WOUND TYPE, 2018–2025 (USD MILLION)
        • Table MEXICO: BIOFILMS TREATMENT MARKET, BY END USER, 2018–2025 (USD MILLION)
      • REST OF LATIN AMERICA
        • Table ROLATAM: BIOFILMS TREATMENT MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
        • Table ROLATAM: BIOFILMS TREATMENT MARKET, BY WOUND TYPE, 2018–2025 (USD MILLION)
        • Table ROLATAM: BIOFILMS TREATMENT MARKET, BY END USER, 2018–2025 (USD MILLION)
    • MIDDLE EAST & AFRICA
      • GROWING PREVALENCE OF DIABETES TO SUPPORT MARKET GROWTH
        • Table MIDDLE EAST & AFRICA: BIOFILMS TREATMENT MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: BIOFILMS TREATMENT MARKET, BY WOUND TYPE, 2018–2025 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: BIOFILMS TREATMENT MARKET, BY END USER, 2018–2025 (USD MILLION)
  • COMPETITIVE LANDSCAPE
    • INTRODUCTION
    • MARKET SHARE ANALYSIS, 2019
      • BIOFILMS TREATMENT MARKET, BY KEY PLAYER
      • BIOFILMS TREATMENT MARKET FOR HOSPITALS
      • BIOFILMS TREATMENT MARKET FOR HOME CARE SETTINGS
    • COMPETITIVE LEADERSHIP MAPPING (OVERALL MARKET)
    • VENDOR INCLUSION CRITERIA
    • VENDOR DIVE
      • VISIONARY LEADERS
      • INNOVATORS
      • DYNAMIC DIFFERENTIATORS
      • EMERGING COMPANIES
    • COMPETITIVE SCENARIO
      • PRODUCT LAUNCHES & APPROVALS
      • ACQUISITIONS
      • COLLABORATIONS & PARTNERSHIPS
  • COMPANY PROFILES
    • SMITH AND NEPHEW PLC
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • MIMEDX GROUP
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • MNM VIEW
    • CONVATEC GROUP PLC
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • INTEGRA LIFESCIENCES HOLDINGS CORPORATION
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • PAUL HARTMANN AG
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • MÖLNLYCKE HEALTH CARE AB
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • COLOPLAST A/S
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • B. BRAUN MELSUNGEN AG
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • ORGANOGENESIS HOLDINGS INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • MISONIX
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • ACELITY (A PART OF 3M)
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • ZIMMER BIOMET HOLDINGS INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
    • KERECIS
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • MEDLINE INDUSTRIES, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • WELCARE INDUSTRIES S.P.A
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
    • MEDAXIS AG
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
    • PULSECARE MEDICAL
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
    • AROBELLA MEDICAL, LLC
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
    • ADVANCIS MEDICAL
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
    • RLS GLOBAL AB
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • MIL LABORATORIES PVT. LTD.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
  • APPENDIX
    • DISCUSSION GUIDE
    • KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
    • AVAILABLE CUSTOMIZATIONS
    • RELATED REPORTS
    • AUTHOR DETAILS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook